Minireviews
Copyright ©The Author(s) 2018.
World J Gastroenterol. May 7, 2018; 24(17): 1881-1887
Published online May 7, 2018. doi: 10.3748/wjg.v24.i17.1881
Table 1 Effects of olfactomedin-4 in digestive diseases
DiseaseExpressionFunctionRegulation
H. pylori infectionUp-regulated in the H. pylori–infected gastric mucosaNegative regulator of H. pylori-specific immune responsesNF-κB, NOD-1/2, MyD88
Inflammatory bowel diseaseUp-regulated in the intestinal epithelium in Crohn’s disease and ulcerative colitisMucosal defense, anti-inflammatory effectsNotch, TNF-α
Gastrointestinal malignanciesUp-regulated in well/moderately differentiated, early-stage gastrointestinal malignancies without lymphatic metastasisBiomarker, candidate therapeutic targetNF-κB, TNF-α, miR-486, Wnt/β-catenin